Literature DB >> 1712697

The role of TGF-beta in pulmonary fibrosis.

N Khalil1, A H Greenberg.   

Abstract

Pulmonary fibrosis is an irreversible accumulation of connective tissue in the interstitium of the lung. The pathogenesis of pulmonary fibrosis is not well understood. Research on animal models and studies of human lung disease suggest the initiating events may be a combination of pulmonary injury and the recruitment of inflammatory cells, mainly macrophages. A number of well characterized cytokines, including TGF-beta, have been either found in the injured lung or produced by inflammatory cells removed from the lung. In an animal model of pulmonary fibrosis, TGF-beta production is increased prior to collagen synthesis and is mainly produced by alveolar macrophages. In advanced idiopathic pulmonary fibrosis, a human fibrotic lung disease, extensive TGF-beta deposition can be detected by immunohistochemical staining, primarily in epithelial cells in areas of lung regeneration and remodelling. This suggests that the pathogenesis of the progressive fibrosis characteristic of this lung disease may be an aberrant repair process.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1712697     DOI: 10.1002/9780470514061.ch13

Source DB:  PubMed          Journal:  Ciba Found Symp        ISSN: 0300-5208


  35 in total

Review 1.  The pulmonary physician in critical care * 6: The pathogenesis of ALI/ARDS.

Authors:  G J Bellingan
Journal:  Thorax       Date:  2002-06       Impact factor: 9.139

Review 2.  Extracellular matrix and lung inflammation.

Authors:  J Roman
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

3.  Titration of non-replicating adenovirus as a vector for transducing active TGF-beta1 gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice.

Authors:  G Sakuntala Warshamana; Derek A Pociask; Krishna J Fisher; Jing-Yao Liu; Patricia J Sime; Arnold R Brody
Journal:  Int J Exp Pathol       Date:  2002-08       Impact factor: 1.925

4.  Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4.

Authors:  Dianhua Jiang; Jiurong Liang; Gabriele S Campanella; Rishu Guo; Shuang Yu; Ting Xie; Ningshan Liu; Yoosun Jung; Robert Homer; Eric B Meltzer; Yuejuan Li; Andrew M Tager; Paul F Goetinck; Andrew D Luster; Paul W Noble
Journal:  J Clin Invest       Date:  2010-05-17       Impact factor: 14.808

5.  Myosin heavy chain 15 is associated with bovine pulmonary arterial pressure.

Authors:  Marianne T Neary; Joseph M Neary; Gretchen K Lund; Timothy N Holt; Franklyn B Garry; Timothy J Mohun; Ross A Breckenridge
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

6.  Hepatocyte growth factor inhibits epithelial to myofibroblast transition in lung cells via Smad7.

Authors:  Manasi N Shukla; Jane L Rose; Rabindranath Ray; Kira L Lathrop; Anuradha Ray; Prabir Ray
Journal:  Am J Respir Cell Mol Biol       Date:  2008-11-06       Impact factor: 6.914

7.  Respiratory syncytial virus infection reduces lung inflammation and fibrosis in mice exposed to vanadium pentoxide.

Authors:  Elizabeth A Turpin; Aurita Antao-Menezes; Mark F Cesta; James B Mangum; Duncan G Wallace; Edilberto Bermudez; James C Bonner
Journal:  Respir Res       Date:  2010-02-22

8.  Interferon-alpha inhibits murine macrophage transforming growth factor-beta mRNA expression.

Authors:  S Dhanani; M Huang; J Wang; S M Dubinett
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

9.  A review of current and novel therapies for idiopathic pulmonary fibrosis.

Authors:  Rokhsara Rafii; Maya M Juarez; Timothy E Albertson; Andrew L Chan
Journal:  J Thorac Dis       Date:  2013-02       Impact factor: 2.895

Review 10.  Acute lung injury and acute respiratory distress syndrome.

Authors:  Anil Vasudevan; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.